Integrin alpha6 Activity in Castration-Resistant Prostate Cancer
<p> Although castration-resistant prostate cancers no longer respond to anti-androgen therapies, the androgen receptor (AR) is still required to promote tumor survival. However, the signaling pathways downstream of AR that promote this survival are not well known. We recently identified an AR-...
| Main Author: | |
|---|---|
| Language: | EN |
| Published: |
Van Andel Research Institute
2017
|
| Subjects: | |
| Online Access: | http://pqdtopen.proquest.com/#viewpdf?dispub=10289534 |